Expert Review of Molecular Diagnostics · 2021 · 12 citations · 13 references
MedicineMolecular MedicineOncologyEarly DetectionMolecular DiagnosticsMolecular OncologyAssay ValidationBioanalytical Method ValidationBiomarker ValidationCancer BiomarkersCancer Molecular DiagnosticsLiquid BiopsyAnalytical AccuracyAnalytical SensitivityAssay ReproducibilityCell-free Dna Methylation BiomarkersCirculating Cell-free Dna AnalysisEarly Stage Disease DetectionHepatic BiomarkersHepatocellular Carcinoma Surveillance
INTRODUCTION: Surveillance is essential to diagnose and more effectively treat hepatocellular carcinoma (HCC) in at-risk patients. However, the performance of currently recommended surveillance strategies is suboptimal, particularly for early-stage detection, and patient adherence remains low. Here, we establish the analytical performance of a novel liquid biopsy test to evaluate the presence of HCC. METHODS: ), the protein biomarker α-fetoprotein (AFP), and patient sex. The methylation markers are quantified from cell-free DNA extracted from plasma, and AFP is measured from serum. We conducted analytical validation studies on the mt-HBT, including analytical sensitivity, linearity, cross-contamination, interference, analytical accuracy, and precision. RESULTS: The mt-HBT performance met all pre-specified analytical performance criteria. The test demonstrated high reproducibility, with ≥97% concordance relative to the expected results for six categories of surrogate samples across the test's dynamic range. Of 17 candidate interfering substances, none caused significant interference to biomarker quantitation, and no occurrences of sample-to-sample cross-contamination were observed. CONCLUSION: These data demonstrate that the mt-HBT can produce consistent, reliable results for patients in the intended-use population, for whom surveillance is recommended.
13
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text
The National Comprehensive Cancer Network
William T. McGivney · Cancer · 1998 · 16.9K citations
American Association of Industrial Nurses Journal · 1968 · 8.9K citations
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach, Laura Kulik, Richard S. Finn et al. · Hepatology · 2017 · 4.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +12